Venous thromboembolism and liver cirrhosis;Enfermedad tromboembólica venosa y cirrosis hepática

Revista Espanola de Enfermedades Digestivas

Volumn 100, Issue 5, 2008, Pages 259-262

  García Fuster, María José ^a   Abdilla, N ^a   Fabia M J ^a   Fernandez C ^a   Oliver, V ^a   Forner, M J ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Coagulopathy and cirrhosis; Thrombosis and hepatic failure; Venous thromboembolism and hepatopathy

Indexed keywords

ANTITHROMBIN III; PHOSPHOLIPID ANTIBODY; PROTEIN C; SERUM ALBUMIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD EXAMINATION; BLOOD TRANSFUSION; FEMALE; HOSPITAL PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LIVER CIRRHOSIS; MALE; PROTEIN S DEFICIENCY; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE COUNT; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VENOUS THROMBOEMBOLISM;

EID: 47049097607     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Oka K, Tanaka K. Intravascular coagulation in autopsy cases with liver diseases. Thromb Haemost 1979; 42: 564-70.
2. Kalambokis G, Svarna E, Tsianos EV. Long-term anticoagulation therapy for a cirrothic patient with recurrent deep venous thrombosis. J Gastroenterol Hepatol 2005; 20: 1803-4.
3. Espiritu J. Pulmonary embolism in a patient with coagulopathy from end-stage liver disease. Chest 2000; 117: 924-5.
4. Northup P, McMahon M, Ruhl A, Altschuler S, Volk-Bednarz A, Caldwell S, et al. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol 2006; 101: 1524-8.
5. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126: 401S-28S.
6. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts [see comment]. Hepatology 2000; 31: 864-71.
7. Schrecengost JE, LeGallo RD, Boyd JC, Moons KG, Gonias SL, Rose CE Jr, et al. Comparison of diagnostic accuracies in outpatients and hospitalized patients of D-dimer testing for evaluation of suspected pulmonary embolism. Clin Chem 2003; 49: 1483-90.
8. Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, et al., and the Coagulation in Liver Disease Group. Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current management. Hepatology 2006; 44: 1039-46.
9. Violi F, Ferro D, Basili S, D'Angelo A, Mazzola G, Quintarelli C, et al. Relation between lupus anticoagulant and splachnic venous thrombosis in cirrhosis of liver. BMJ 1994; 309: 239-40.
10. Fernández-Miranda C, Martínez Prieto M, Casis Herce B, Sánchez Gómez F, Gómez González P, Martínez López J, et al. Hiperhomocisteinemia y mutaciones de la metilentetrahidrofolato reductasa 677C-T y 1298A-C en pacientes con enfermedad inflamatoria intestinal. Rev Esp Enferm Dig 2005; 97 (7): 497-504.
11. Carmassi F, Morale M, De Negri F, Carrai M. Modulation of hemostatic balance with antithrombin III replacement therapy in a case of liver cirrhosis associated with recurrent venous thrombosis. J Mol Med 1995; 73: 89-93.